AMANDA MASON: Open Payments
NPI 1770919649 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 21 payments from 10 companies in 2025. Trend: 2023 $68 · 2024 $60 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $78 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $46 |
| Ascensia Diabetes Care Us Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, SHINGRIX, ELIQUIS, Rybelsus, Ozempic, PREVNAR 20, AREXVY.
Industry payments across MI — which companies pay providers there.
